Skip to main content

HH&L Acquisition Co.

HHLADelisted Feb 23, 2024
Industry
Services-Medical Laboratories
SEC CIK
0001824185

HH&L Acquisition Co. was delisted on Feb 23, 2024; its insiders filed their last Form 4 on Jan 12, 2024; 19 institutions reported holding it in 13F filings for Q4 2023, worth $40.1M in total; no superinvestor held it.

Q4 2023 vs. Q3 2023

How the institutions holding HH&L Acquisition Co. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of HHLA: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders1719+2
Shares3.90M3.73M−171.5K (−4.4%)
Value$41.4M$40.1M−$1.25M (−3.0%)

New holders (5)

Institutions that held HH&L Acquisition Co. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to HHLA in Q4 2023
InstitutionSharesValue% of portfolio
JPMorgan Chase & Co401,967$4.30M0.00%
Kim, LLC156,969$1.69M0.17%
Walleye Capital LLC87,374$934.9K0.01%
Westchester Capital Management, LLC58,003$621.2K0.02%
Walleye Trading LLC43,807$468.7K0.01%

Sold out (3)

Institutions that held HH&L Acquisition Co. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of HHLA in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Castle Creek Arbitrage, LLC403,771$4.29M
Caas Capital Management LP58,594$622.3K
Fifth Lane Capital, LP1$11